1. Vaccine makers Pfizer and Moderna pledge massive boost to U.S. supply after sluggish rollout  The Washington Post
  2. Should you wait for a better vaccine?  NEWS.com.au
  3. Greg Hunt provides an update on the COVID-19 vaccine rollout | ABC News  ABC News (Australia)
  4. The Guardian view on Boris Johnson's Covid plan: a risky bet on vaccines  The Guardian
  5. Quiet dignity: Prince William makes private donation to charity after 'horrific' attack  Express
  6. View Full coverage on Google News

Shares of Johnson & Johnson undefined were down 0.1% in premarket trading on Tuesday after the company said in testimony released in advance of a...Shares of Johnson & Johnson undefined were down 0.1% in premarket trading on Tuesday after the company said in testimony released in advance of a...

J&J plans to deliver 20 million doses of its COVID-19 vaccine in the U.S. in March - MarketWatch

Federally Qualified Health Centers could be key to vaccinating hard-hit populations, experts say. They're now set to get extra doses.Federally Qualified Health Centers could be key to vaccinating hard-hit populations, experts say. They're now set to get extra doses.

COVID vaccine: Low-income clinics gear up to receive extra doses

<strong>Editorial: </strong>The more we allow infections to rise and the virus to replicate, the greater the chance that new variants will arrive that have the ability to evade our defencesEditorial: The more we allow infections to rise and the virus to replicate, the greater the chance that new variants will arrive that have the ability to evade our defences

The Guardian view on Boris Johnson's Covid plan: a risky bet on vaccines | Coronavirus | The Guardian

Overstating or overemphasizing vaccine hesitancy can keep others from deciding to get the COVID-19 shots.Overstating or overemphasizing vaccine hesitancy can keep others from deciding to get the COVID-19 shots.

Op-Ed: Emphasize vaccine acceptance, not hesitancy - Los Angeles Times

Welcome to Monday's Overnight Health Care. It's going to be a busy week, so make sure you're properly caffeinated.Welcome to Monday's Overnight Health Care. It's going to be a busy week, so make sure you're properly caffeinated.

Overnight Health Care: US surpasses half a million COVID deaths | House panel advances Biden's $1.9T COVID-19 aid bill | Johnson & Johnson ready to provide doses for 20M Americans by end of March | TheHill

Welcome to Monday's Overnight Health Care. It's going to be a busy week, so make sure you're properly caffeinated.Welcome to Monday's Overnight Health Care. It's going to be a busy week, so make sure you're properly caffeinated.

Overnight Health Care: US surpasses half a million COVID deaths | House panel advances Biden's $1.9T COVID-19 aid bill | Johnson & Johnson ready to provide doses for 20M Americans by end of March | TheHill

403 Forbidden

Pfizer and Moderna said they're ramping up their supply of coronavirus vaccines, with shipments expected to double and possibly triple, according to congressional testimony.Pfizer plans to increase weekly shipments to more than 13 million doses, while Moderna is aiming for 40 million doses monthly.

Executives with Pfizer, Moderna say they're ramping up vaccine supplies

As deaths top 500K and cases trend downward, US pandemic fight at 'crossroads'

Moderna said it received "positive feedback" from the FDA on its proposal to increase the number of Covid-19 vaccine doses in each of its vials.Moderna said it received "positive feedback" from the FDA on its proposal to increase the number of Covid-19 vaccine doses in each of its vials.

Winds and blowing snow will create near-blizzard conditions in some areas.Winds and blowing snow will create near-blizzard conditions in some areas.

Moderna’s president, Dr. Stephen Hoge, plans to tell lawmakers Tuesday that the company received “positive feedback” from the Food and Drug Administration to increase the doses in each vial of vaccine from ten to 15.Moderna’s president, Dr. Stephen Hoge, plans to tell lawmakers Tuesday that the company received “positive feedback” from the Food and Drug Administration to increase the doses in each vial of vaccine from ten to 15.

Executives from the companies are slated to testify Tuesday morning.Executives from the companies are slated to testify Tuesday morning.

Pfizer and Moderna expect to double vaccine shipments by spring - Axios

The North Philadelphia clinic will have the capacity to vaccinate up to 500 people a day.The North Philadelphia clinic will have the capacity to vaccinate up to 500 people a day.

COVID-19 news: Third stimulus checks on track to arrive in mid-March, Biden tweaks Paycheck Protection Program

Dr. Samir Sinha says if the goal is to prevent deaths, lessen the strain on the health-care system or reopen the economy, the approach is the same: vaccinate seniors first.Dr. Samir Sinha says if the goal is to prevent deaths, lessen the strain on the health-care system or reopen the economy, the approach is the same: vaccinate seniors first.

Should all seniors get the COVID-19 vaccine before essential workers? | Globalnews.ca

The Moderna and Pfizer/BioNTech vaccines currently available are not recommended for children, said Dr. Oluwatosin Goje, an OB/GYN and infectious disease specialist at the Cleveland Clinic. That includes including children under 16 with pre-existing conditions, Goje said.However, COVID-19 vaccines could be authorized for children as young as first grade by September, Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, said recently in an interview with ProPublica.

If Pfizer and Moderna vaccines are for people 16 and older, what does that mean for children? What about minors with pre-existing conditions? - cleveland.com

The U.S. could have 240 million doses of COVID-19 vaccines by the end of March.The U.S. could have 240 million doses of COVID-19 vaccines by the end of March.

Vaccine makers to pledge 240 million doses by end of March

President Joe Biden called the U.S. topping 500,000 coronavirus-related deaths a “truly grim, heartbreaking milestone” during a ceremony at the White House...President Joe Biden called the U.S. topping 500,000 coronavirus-related deaths a “truly grim, heartbreaking milestone” during a ceremony at the White House Monday night. He told the nation that “to heal, we must remember.”

Virus Updates: Pfizer, Moderna Ramping Up Vaccine Supplies – NBC Chicago

Moderna Inc. (NASDAQ: MRNA) said that following positive feedback from the U.S. Food and Drug Administration, it is pursuing a plan to increase the number of COVID-19 vaccine doses to up to 15 in each vial from the present 10 doses. What Happened: The plan was disclosed as part of the biotechnology company’s written testimony ahead of a House hearing scheduled for Tuesday. One vial of Moderna’s two-shot vaccine is currently enough to inoculate five people. The plan to increase the number of doses in each vial will enable Moderna to produce and deliver the vaccine more quickly and also help ease a manufacturing bottleneck. Moderna said in mid-February that while short-term delays in the final stages of production at the company’s fill and finish contractor Catalent delayed the release of some doses, it expects to resolve these delays in the near term and not impact its monthly delivery targets. Why it Matters: The U.S. is facing a vaccine crunch as only 72 million doses were shipped by Pfizer Inc. (NYSE: PFE) and Moderna despite the promise to deliver 200 million doses by the end of March, Reuters reported in February. Several states have complained about not having enough doses to keep up with the pace of demand. In addition, labeling confusion had resulted in hospital pharmacists discarding one in every six doses of the vaccine made jointly by Pfizer and its German partner BioNTech SE (NASDAQ: BNTX), StatNews reported earlier. But the FDA later advised that every dose obtainable may be fully used, given the public health emergency. President Joe Biden reportedly announced in mid-February that his administration has secured deals with Pfizer and Moderna for a total of 600 million COVID-19 vaccines. The 600 million doses of the two-shot vaccines would be enough to inoculate 300 million people. Pfizer in a written testimony ahead of the hearing also said it expected to ramp up the supply of the COVID-19 vaccine in the coming weeks, shipping about 13 million doses a week by mid-March. Johnson & Johnson (NYSE: JNJ) said its supply could be enough to inoculate 20 million people by the end of next month. Price Action: Moderna shares closed 8.8% lower at $159.37 on Monday, but rose 0.6 percent in the after-hours session. See more from BenzingaClick here for options trades from BenzingaBitcoin Might Be Tanking But These Ethereum Killers Are Posting Major Gains TodayElon Musk Lost B In A Single Day And The Cause Could Be One Of His Own Tweets© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.Moderna Inc. (NASDAQ: MRNA) said that following positive feedback from the U.S. Food and Drug Administration, it is pursuing a plan to increase the number of COVID-19 vaccine doses to up to 15 in each vial from the present 10 doses. What Happened: The plan was disclosed as part of the biotechnology company’s written testimony ahead of a House hearing scheduled for Tuesday. One vial of Moderna’s two-shot vaccine is currently enough to inoculate five people. The plan to increase the number of doses in each vial will enable Moderna to produce and deliver the vaccine more quickly and also help ease a manufacturing bottleneck. Moderna said in mid-February that while short-term delays in the final stages of production at the company’s fill and finish contractor Catalent delayed the release of some doses, it expects to resolve these delays in the near term and not impact its monthly delivery targets. Why it Matters: The U.S. is facing a vaccine crunch as only 72 million doses were shipped by Pfizer Inc. (NYSE: PFE) and Moderna despite the promise to deliver 200 million doses by the end of March, Reuters reported in February. Several states have complained about not having enough doses to keep up with the pace of demand. In addition, labeling confusion had resulted in hospital pharmacists discarding one in every six doses of the vaccine made jointly by Pfizer and its German partner BioNTech SE (NASDAQ: BNTX), StatNews reported earlier. But the FDA later advised that every dose obtainable may be fully used, given the public health emergency. President Joe Biden reportedly announced in mid-February that his administration has secured deals with Pfizer and Moderna for a total of 600 million COVID-19 vaccines. The 600 million doses of the two-shot vaccines would be enough to inoculate 300 million people. Pfizer in a written testimony ahead of the hearing also said it expected to ramp up the supply of the COVID-19 vaccine in the coming weeks, shipping about 13 million doses a week by mid-March. Johnson & Johnson (NYSE: JNJ) said its supply could be enough to inoculate 20 million people by the end of next month. Price Action: Moderna shares closed 8.8% lower at $159.37 on Monday, but rose 0.6 percent in the after-hours session. See more from BenzingaClick here for options trades from BenzingaBitcoin Might Be Tanking But These Ethereum Killers Are Posting Major Gains TodayElon Musk Lost B In A Single Day And The Cause Could Be One Of His Own Tweets© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Moderna Prepares To Increase Doses In Each COVID-19 Vaccine Vial To Counter Production Woes

Why did the vaccine rollout start so slowly? And other questions we hope lawmakers ask the Covid-19 vaccine makers. Why did the vaccine rollout start so slowly? And other questions we hope lawmakers ask the Covid-19 vaccine makers. 

The questions Congress should ask pharma about the Covid-19 vaccines

Gov. John Bel Edwards’ administration has quietly added new groups of people to the next phase of vaccine priority, giving clergy, veterinarians and the faculty and staff of colleges andGov. John Bel Edwards’ administration has quietly added new groups of people to the next phase of vaccine priority, giving clergy, veterinarians and the faculty and staff of colleges and

Who's in the next coronavirus vaccine priority group in Louisiana? Higher education, clergy, more | Coronavirus | theadvocate.com

Drugmaker Johnson & Johnson says it will be able to provide 20 million U.S. doses of its single-shot COVID-19 vaccine by the end of March, assuming it gets the greenlight from federal regulators.U.S. health regulators are still reviewing the safety and effectiveness of the shot and a decision to allow its emergency use is expected later this week.

Johnson and Johnson says it will be able to provide 20 million COVID-19 vaccine doses by end of March | abc7.com

The Trump and Biden administrations both imposed wartime production requirements. But industry experts say the vast quantities of raw materials and specialty equipment needed for billions of newfangled vaccines have required herculean logistical efforts.The Trump and Biden administrations both imposed wartime production requirements. But industry experts say the vast quantities of raw materials and specialty equipment needed for billions of newfan…

After Billions of Dollars and Dozens of Wartime Declarations, Why Are Vaccines Still in Short Supply? | Kaiser Health News

The Trump and Biden administrations both imposed wartime production requirements. But industry experts say the vast quantities of raw materials and specialty equipment needed for billions of newfan…

After Billions of Dollars and Dozens of Wartime Declarations, Why Are Vaccines Still in Short Supply? – Kaiser Health News

The New Brunswick-based pharmaceutical giant will be able to deliver 20 million doses of its single-shot vaccine by the end of March.

Johnson & Johnson will have enough vaccine for 20M people by end of March, N.J. pharma giant says - nj.com

Johnson & Johnson said Monday that it plans to have enough doses of its vaccine for more than 20 million Americans by the end of March if its vaccine is authorized by the Food and Drug Administration.Johnson & Johnson said Monday that it plans to have enough doses of its vaccine for more than 20 million Americans by the end of March if its vaccine is authorized by the Food and Drug Administration.

Johnson & Johnson ready to provide doses for 20M Americans by end of March | TheHill

Johnson & Johnson said Monday that it plans to have enough doses of its vaccine for more than 20 million Americans by the end of March if its vaccine is authorized by the Food and Drug Administration.Johnson & Johnson said Monday that it plans to have enough doses of its vaccine for more than 20 million Americans by the end of March if its vaccine is authorized by the Food and Drug Administration.

Johnson & Johnson ready to provide doses for 20M Americans by end of March | TheHill

Richard Nettles, vice president of medical affairs for the company's pharmaceutical unit Janssen, plans to tell a House Energy & Commerce subcommittee that assuming necessary regulatory approvals relating to our manufacturing processes, the plan is to begin shipping...Johnson & Johnson is gearing up to deliver 20 million doses of its new coronavirus vaccine to the U.S. government by the end of March and is "confident" of being able to supply 100 million of the single-dose shots during the first half of 2021, a company official is expected to...

Johnson & Johnson: Can Provide 20M Vaccine Doses by End of March | Newsmax.com

A House Commerce subcommittee hearing is being held with COVID-19 vaccine manufacturers to discuss the country's vaccine supply.A House Commerce subcommittee hearing is being held with COVID-19 vaccine manufacturers to discuss the country's vaccine supply.

Congressional hearing set to discuss country's COVID-19 vaccine supply

Government bungled the vaccine rollout such that after the AstraZenneca controversy it withheld information on last week's limited vaccine trial on health workers which was presented as the start of a vaccine rollout programme.Government bungled the vaccine rollout such that after the AstraZenneca controversy it withheld information on last week's limited vaccine trial on health workers which was presented as the start of a vaccine rollout programme.

J&J vaccine is not yet official, say experts

Pfizer is on track to deliver 120 million doses of its two-dose regimen by the end of March, said John Young, Pfizer's chief business officer.Pfizer is on track to deliver 120 million doses of its two-dose regimen by the end of March, said John Young, Pfizer's chief business officer.

Pfizer to ship 13m. COVID-19 vaccine doses per week to US by mid-March - The Jerusalem Post

Moderna hopes to double its delivery from 20 million doses per month to 40 million while Johnson & Johnson said it can deliver 20 million doses next month if its shot is approved by the FDA>.Moderna hopes to double its delivery from 20 million doses per month to 40 million while Johnson & Johnson said it can deliver 20 million doses next month if its shot is approved by the FDA>.

Moderna aims to DOUBLE its COVID-19 vaccine production and deliver 40 million dose per month | Daily Mail Online

The U.S. Food and Drug Administration could approve the one-dose coronavirus vaccine made by Johnson & Johnson as early as Friday.The U.S. Food and Drug Administration could approve the one-dose coronavirus vaccine made by Johnson & Johnson as early as Friday.

Single-dose Johnson & Johnson vaccine could be approved Friday :: WRAL.com

Pfizer Inc expects to deliver more than 13 million doses of its COVID-19 vaccine per week to the United States by the middle of March, more than ...Pfizer Inc expects to deliver more than 13 million doses of its COVID-19 vaccine per week to the United States by the middle of March, more than ...

Pfizer to ship 13 million COVID-19 vaccine doses per week to US by mid-March: Executive - CNA

Governor Andrew Cuomo's political troubles received more national attention during the cold open on NBC's Saturday Night Live.Governor Andrew Cuomo's political troubles received more national attention during the cold open on NBC's Saturday Night Live.

Current Wyoming law bans abortions prior to the age where the fetus is considered viable to live outside the womb.Current Wyoming law bans abortions prior to the age where the fetus is considered viable to live outside the womb.

Pfizer and Moderna to the rescue?Pfizer and Moderna to the rescue?

Fauci: Don't expect Johnson & Johnson to have "front-loaded" doses when FDA approves vaccine

hotair.com

Fauci: Don't expect Johnson & Johnson to have "front-loaded" doses when FDA approves vaccine

Inevitably Boris Johnson’s cautious roadmap to lead Britain out of lockdown was greeted with protests from the usual suspects. The prime minister confirmed that all schools would reopen as previouslyInevitably Boris Johnson’s cautious roadmap to lead Britain out of lockdown was greeted with protests from the usual suspects. The prime minister confirmed that all schools would reopen as previously

WASHINGTON (AP) — Executives from the major COVID-19 vaccine producers answered questions Tuesday from Congress about expanding the supply of shots needed to curb the pandemic that has killed more than 500,000 Americans. The hearing comes as U.S. vaccinations continue to accelerate after a sluggish start and recent disruptions caused by winter weather. But state […]WASHINGTON (AP) — Executives from the major COVID-19 vaccine producers answered questions Tuesday from Congress about expanding the supply of shots needed to curb the pandemic that has killed more …

KXAN Austin